Trial intelligence / Profile preview

Dexamethasone versus normal saline for prevention of post-dural puncture headache after spinal anaesthesia for caesarean section

PACTR202607554113342Not yet recruiting

Sponsor
Auwalu Shuaibu
Start
Nov 2026
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Trial of dexamethasone in post-dural puncture headache (PDPH) (2 arms), sponsored by Auwalu Shuaibu. Primary endpoints: Prevention of post-dural puncture headache and Prevalence of post-dural puncture headache. Planned start Nov 2026; status: not yet recruiting.

02

Drugs

dexamethasone
03

Conditions

post-dural puncture headache (PDPH)

Beyond the preview

Go deeper on PACTR202607554113342.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202607554113342.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call